Parmax Pharma Limited
BSE: PARMAX.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Umang Alkesh Gosalia
- Employees
- 9
- Headquarters
- Rajkot, India
- IPO year
- 2024
- Market cap
- ₹123.4M
- Website
- https://www.parmaxpharma.com
Loading PARMAX…
Loading profile data…Frequently asked questions about PARMAX
What does Parmax Pharma Limited (PARMAX.BO) do?
Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company also plans to extend its activities in formulation of tablets, capsules, ointments, & injectable. The company was founded on November 2, 1994 and is headquartered in Rajkot, India.
Where does PARMAX.BO trade?
Parmax Pharma Limited (PARMAX.BO) trades on the Bombay Stock Exchange.
What sector is PARMAX.BO in?
Parmax Pharma Limited (PARMAX.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Parmax Pharma Limited?
Umang Alkesh Gosalia is the chief executive officer of Parmax Pharma Limited (PARMAX.BO).
Where is Parmax Pharma Limited headquartered?
Parmax Pharma Limited is headquartered in India.
Does PARMAX.BO pay a dividend?
Parmax Pharma Limited (PARMAX.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PARMAX.BO go public?
Parmax Pharma Limited (PARMAX.BO) completed its initial public offering in 2024.